Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides

Published:2017-03-21 Issue:6 Volume:19 Page:710-717
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

D'Elia Emilia¹,Iacovoni Attilio¹,Vaduganathan Muthiah²,Lorini Ferdinando L.³,Perlini Stefano⁴,Senni Michele¹

Affiliation:

1. Cardiovascular Department; Hospital Papa Giovanni XXIII; Bergamo Italy

2. Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School; Boston MA USA

3. Anesthesiology Department; Hospital Papa Giovanni XXIII; Bergamo Italy

4. Internal Medicine Department, IRCCS Polyclinic San Matteo; University of Pavia; Pavia Italy

Funder

Novartis Pharma AG, Basel, Switzerland

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference77 articles.

1. Heart failure;McMurray;Lancet,2005

2. The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment;Volpe;Clin Sci (Lond),2016

3. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. Sacubitril/valsartan (LCZ696) for the treatment of heart failure;Gori;Expert Rev Cardiovasc Ther,2016

5. Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances;McMurray;Eur J Heart Fail,2015

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of senescence related hub genes and potential therapeutic compounds for dilated cardiomyopathy via comprehensive transcriptome analysis;Computers in Biology and Medicine;2024-09

2. A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system;Frontiers in Pharmacology;2024-08-13

3. Inibidores da Neprilisina: Histórico, Farmacologia, Evidência Farmacológico-clínica e Prática Clínica, do Risco de Angioedema ao Pilar Terapêutico na Insuficiência Cardíaca;ABC Heart Failure & Cardiomyopathy;2024-07-11

4. Emerging therapies targeting cardiovascular risk factors to prevent or delay the onset of heart failure;American Journal of Pharmacotherapy and Pharmaceutical Sciences;2024-07-09

5. Cellular metabolism of substance P produces neurokinin-1 receptor peptide agonists with diminished cyclic AMP signaling;American Journal of Physiology-Cell Physiology;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3